MACS® GMP Recombinant Human IL-15

Interleukin 15 (IL-15) is a potent lymphoid cell growth factor and stimulates the proliferation of activated T cells and the generation of cytotoxic T lymphocytes (CTLs). IL-15 also induces the generation, activation, and proliferation of NK cells.

MACS GMP Recombinant Human IL-15 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Choose your product:

Related products for MACS® GMP Recombinant Human IL-15

Specifications for MACS® GMP Recombinant Human IL-15
Overview

Interleukin 15 (IL-15) is a potent lymphoid cell growth factor and stimulates the proliferation of activated T cells and the generation of cytotoxic T lymphocytes (CTLs). IL-15 also induces the generation, activation, and proliferation of NK cells.

MACS GMP Recombinant Human IL-15 is designed for ex vivo cell culture processing. No animal- or human-derived materials were used for the manufacture of this product, unless otherwise stated in the respective Certificate of Origin. The product is lyophilized without carrier protein or preservatives.

Detailed product information

Biological activity

Determination method
The specific activity is determined by proliferation assay according to Soman et al.1 using CTLL-2 cells. The proliferation assay was calibrated with the reference standard for human IL-15 (NIBSC code 95/554) provided by the National Institute for Biological Standards and Control.
Minimal specific activity
≥ 7×106 U/mg
Typical specific activity
≥ 2×107 IU/mg
Background information

IL-15 is a member of the four α-helix bundle cytokine family. It is produced by different cell types, including epithelial cells, monocytes, muscle and placenta cells. In addition to its ability to activate T cells and NK cells, IL-15 is also important for B cell growth and immunoglobulin production as well as for the maintenance of CD8+ memory T cells. For binding and signaling IL-15 uses the unique IL-15 receptor α-chain, but shares the β- and γ-chain of the IL-2 receptor.

Applications

MACS GMP Recombinant Human IL-15 can be used for a variety of applications, including the ex vivo generation of cytotoxic T lymphocytes2,3 or the ex vivo stimulation of NK cells4,5.

Technical specifications

  • Identity/ Molecular mass: 12.770 Da, determined by mass spectrometry. This corresponds to the mature form of human IL-15 (114 amino acids).
  • Purity: ≥ 95 % as determined by chip electrophoresis.
  • Product related impurities: ≤ 10 % as determined by chip electrophoresis.
  • Endotoxin content: < 100 EU/mg, as determined by kinetic Limulus Amoebocyte Lysate (LAL) assay (Pharmacopoeia Europaea (Ph. Eur.)).
  • Residual host cell DNA content: < 20 ng/mg, as determined by quantitative PCR specific for E. coli genomic DNA.
  • Residual host cell protein content: < 10 µg/mg, as determined by E. coli HCP ELISA.

The product quality certificate of MACS® GMP Recombinant Human IL-15 was adapted. Learn more here

Quality statement

MACS GMP Products are manufactured and tested under a quality management system (ISO 13485) and are in compliance with relevant GMP guidelines. They are designed following the recommendations of USP <1043> on ancillary materials.

Disclaimer

MACS GMP Products are for ex vivo cell processing only, and are not intended for human in vivo applications. For regulatory status in the USA, please contact your local representative.

Product data and images for MACS® GMP Recombinant Human IL-15
Figure 1

Mass spectrometry analysis (ESI-MS) of MACS GMP Recombinant Human IL-15. The peak corresponds to the calculated molecular mass of 12770 Da.

Figure 2

MACS GMP Recombinant Human IL-15 biological activity. Activity of Human IL-15, GMP grade, (blue bar) was compared to another commercially available product (black bar).

Figure 3

MACS GMP Recombinant Human IL-15 batch-to-batch variability. Activity of three different production batches of Human MACS GMP IL-15.

Citations for MACS® GMP Recombinant Human IL-15
Publications
  1. Alves, N. L. et al. (2003) IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102: 2541-2546
  2. Kaneko, S. et al. (2009) IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes. Blood 113: 1006-1015
  3. Cho, D. and Campana, D. (2009) Expansion and activation of natural killer cells for cancer immunotherapy. Korean J. Lab. Med. 29: 89-96
  4. Siegler, U. et al. (2010) Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients. Cytotherapy 12 (6): 750-763
  5. Soman, G. et al. (2009) MTS dye based colorimetric CTLL-2 cell proliferation assay for product release and stability monitoring of interleukin-15: assay qualification, standardization and statistical analysis. J. Immunol. Methods 348: 83-94

You have previously chosen International as your location.
What do you want to do?